OA09123A - Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles. - Google Patents

Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.

Info

Publication number
OA09123A
OA09123A OA59610A OA59610A OA09123A OA 09123 A OA09123 A OA 09123A OA 59610 A OA59610 A OA 59610A OA 59610 A OA59610 A OA 59610A OA 09123 A OA09123 A OA 09123A
Authority
OA
OAPI
Prior art keywords
prevention
pharmaceutical composition
sexually transmitted
transmitted diseases
diseases
Prior art date
Application number
OA59610A
Other languages
English (en)
French (fr)
Inventor
Jacques Julien Augros
Augros Jacques Julien
Original Assignee
Sspl Sa Safe Sex Prod Licens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sspl Sa Safe Sex Prod Licens filed Critical Sspl Sa Safe Sex Prod Licens
Publication of OA09123A publication Critical patent/OA09123A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
OA59610A 1988-07-11 1989-07-11 Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles. OA09123A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11

Publications (1)

Publication Number Publication Date
OA09123A true OA09123A (fr) 1991-10-31

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59610A OA09123A (fr) 1988-07-11 1989-07-11 Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.

Country Status (38)

Country Link
US (1) US5439685A (ru)
EP (1) EP0351301B1 (ru)
JP (1) JPH0774164B2 (ru)
KR (1) KR0143231B1 (ru)
CN (1) CN1035038C (ru)
AP (1) AP108A (ru)
AR (1) AR243381A1 (ru)
AT (1) ATE97570T1 (ru)
BR (1) BR8903523A (ru)
CA (1) CA1341304C (ru)
CZ (1) CZ280722B6 (ru)
DD (1) DD283932A5 (ru)
DE (1) DE68910892T2 (ru)
DK (1) DK173527B1 (ru)
ES (1) ES2062065T3 (ru)
FI (1) FI101595B (ru)
HK (1) HK131095A (ru)
HU (1) HU206634B (ru)
IE (1) IE63115B1 (ru)
IL (1) IL90910A (ru)
LT (1) LT3754B (ru)
LV (1) LV10573B (ru)
MA (1) MA22036A1 (ru)
MD (1) MD406C2 (ru)
MX (1) MX170801B (ru)
MY (1) MY106242A (ru)
NO (1) NO178843C (ru)
NZ (1) NZ229891A (ru)
OA (1) OA09123A (ru)
PL (1) PL161848B1 (ru)
PT (1) PT91108B (ru)
RU (1) RU2065742C1 (ru)
SK (1) SK278614B6 (ru)
TN (1) TNSN89074A1 (ru)
TR (1) TR28353A (ru)
UA (1) UA26124A (ru)
YU (1) YU47899B (ru)
ZA (1) ZA895263B (ru)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
US5846964A (en) * 1993-07-19 1998-12-08 Tokyo Tanabe Company Limited Hepatitis C virus proliferation inhibitor
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2728464B1 (fr) * 1994-12-22 1997-04-30 Innothera Lab Sa Forme galenique unitaire, son procede d'obtention et ses utilisations
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
GB2318292A (en) * 1996-09-12 1998-04-22 Simon Everard Barton Saliva-like protectants
US6287286B1 (en) * 1998-08-25 2001-09-11 Kimberly-Clark Worldwide, Inc. Absorbent article having a reduced viability of candida albicans
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
FR2803208A1 (fr) * 1999-12-29 2001-07-06 Jean Bastien Pasquini Tampon periodique antiseptique et son procede de preparation
ES2357474T3 (es) * 2000-03-07 2011-04-26 Rush-Presbyterian-St.Luke's Medical Center Composiciones y su uso para atrapar e inactivar microbios patógenos y espermatoziodes.
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
GB2412121B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Tampon with malodour counteractant
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
SE0102152L (sv) * 2001-06-18 2002-12-19 Sca Hygiene Prod Ab Ny produkt
DK1506781T3 (da) * 2003-11-03 2005-06-13 Peter-Hansen Volkmann Vaginalplejesammensætning
EP1933856A4 (en) * 2005-08-29 2008-11-19 Sepsicure L L C METHOD OF TREATING OR PREVENTING CONDITIONS INDUCED BY GRAM POSITIVE BACTERIA
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (ko) 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
CN103298519B (zh) 2010-11-12 2016-09-14 犹他大学研究基金会 用于受控式润滑剂传递的阴道内装置
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
KR20140050608A (ko) 2011-04-19 2014-04-29 암즈 파머수티컬 엘엘씨 유해 미생물 저해 방법 및 그를 위한 장벽-형성 조성물
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
DE102020131233A1 (de) * 2020-11-25 2022-05-25 Netzsch Trockenmahltechnik Gmbh Verfahren zur herstellung eines homogenisierten gemischs aus kohlenstoff, schwefel und ptfe
KR102399883B1 (ko) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 압출용 복합고분자 펠릿 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (ru) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
EP0081370A1 (en) * 1981-12-07 1983-06-15 Syntex (U.S.A.) Inc. Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
AU2272883A (en) * 1982-12-22 1984-06-28 Herpes Pharmaceutical Inc. Pharmaceutical compositions of steriods for treatment of herpes simplex infections
DE3346641A1 (de) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silanmodifizierte estergemische
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (nl) * 1986-04-11 1987-11-02 Fundatech Sa Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
FR2614525B1 (fr) * 1987-04-29 1995-11-10 Jacques Augros Tampon en eponge elastique, notamment tampon vaginal
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Also Published As

Publication number Publication date
HUT50445A (en) 1990-02-28
JPH0774164B2 (ja) 1995-08-09
HK131095A (en) 1995-08-24
EP0351301A3 (en) 1990-12-19
FI893340L (fi) 1990-01-12
NZ229891A (en) 1991-01-29
EP0351301B1 (fr) 1993-11-24
DD283932A5 (de) 1990-10-31
UA26124A (uk) 1999-06-07
PT91108A (pt) 1990-02-08
NO892826L (no) 1990-01-12
DK173527B1 (da) 2001-01-29
LTIP1660A (en) 1995-07-25
PT91108B (pt) 1995-01-31
PL280531A1 (en) 1990-05-28
HU206634B (en) 1992-12-28
LT3754B (en) 1996-03-25
DK340289A (da) 1990-01-12
MD406C2 (ru) 1996-06-30
TNSN89074A1 (fr) 1991-02-04
AU625716B2 (en) 1992-07-16
FI101595B1 (fi) 1998-07-31
MA22036A1 (fr) 1991-10-01
EP0351301A2 (fr) 1990-01-17
MY106242A (en) 1995-04-29
CZ280722B6 (cs) 1996-04-17
IL90910A (en) 1994-12-29
ATE97570T1 (de) 1993-12-15
CN1041879A (zh) 1990-05-09
CN1035038C (zh) 1997-06-04
BR8903523A (pt) 1991-11-05
NO892826D0 (no) 1989-07-07
AU3802689A (en) 1990-01-11
DE68910892T2 (de) 1994-05-05
DE68910892D1 (de) 1994-01-05
KR0143231B1 (ko) 1998-07-15
RU2065742C1 (ru) 1996-08-27
IE63115B1 (en) 1995-03-22
AR243381A1 (es) 1993-08-31
NO178843B (no) 1996-03-11
FI101595B (fi) 1998-07-31
DK340289D0 (da) 1989-07-10
NO178843C (no) 1996-06-19
SK423889A3 (en) 1997-11-05
YU47899B (sh) 1996-05-20
KR900001366A (ko) 1990-02-27
LV10573A (lv) 1995-04-20
IE892218L (en) 1990-01-11
LV10573B (en) 1995-08-20
TR28353A (tr) 1996-05-16
US5439685A (en) 1995-08-08
FI893340A0 (fi) 1989-07-10
JPH02167235A (ja) 1990-06-27
MX170801B (es) 1993-09-14
AP108A (en) 1991-02-23
ES2062065T3 (es) 1994-12-16
AP8900133A0 (en) 1989-10-31
IL90910A0 (en) 1990-02-09
CZ423889A3 (en) 1995-12-13
PL161848B1 (pl) 1993-08-31
CA1341304C (fr) 2001-10-09
YU135789A (en) 1992-05-28
SK278614B6 (en) 1997-11-05
ZA895263B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
OA09123A (fr) Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
HU895444D0 (en) Process for the preparation of ophthalmic pharmaceutical composition
MA22443A1 (fr) Procede de preparation d'une composition pharmaceutique .
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
DE69114871D1 (de) Homokinetisches Universalgelenk des Plungertyps.
BE891987A (fr) Composition pharmaceutique pour le traitement des maladies de la cavite buccale
NO905327D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
DZ1351A1 (fr) Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
FR2647115B1 (fr) Composition pharmaceutique de nedocromil sodique
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
FR2668707B1 (fr) Procede de preparation d'une composition pharmaceutique.
FR2626961B3 (fr) Coupelle pour bougies
AU625716C (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
MA26546A1 (fr) Composition pharmaceutique pour le traitement de la dysmenorrhee et les accouchements prematures.
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
FR2770132B1 (fr) Composition pharmaceutique pour le traitement de l'arteriopathie des membres inferieurs
FR2636239B1 (fr) Composition desinfectante pour la prevention de la mammite subclinique chez les ruminants
FR2733911B1 (fr) Composition pharmaceutique pour maladies renales ou cardio-vasculaires
FR2652747B1 (fr) Application d'agents actifs pour la preparation d'un medicament destine au traitement de maladies auto-immunes.